Medication Assisted Treatment (MAT): Application, Medications Used, Misconception and Effectiveness

Medication-assisted treatment (MAT) combines medication with counseling and behavioral therapies to treat substance use disorders. The review “Medication-Assisted Treatment FAQ”, from the Illinois Department of Public Health, MAT is the use of medication, and psychotherapy to treat substance addiction. MAT is a whole-patient approach that addresses the physical and psychological aspects of addiction, and helps people to recover from addiction and live healthier lives. 

MAT is used in addiction treatment programs to reduce cravings and manage withdrawal symptoms, making it easier for individuals to focus on their recovery journey.According to the review “Medication for Addiction Treatment”, from the Office of Addiction Services and Supports, MAT is used to treat the whole person using medication, psychosocial interventions and support in the treatment of substance disorder.

MAT uses medications such as methadone, buprenorphine (often combined with naloxone as Suboxone), and naltrexone. According to the review “Information about Medications for Opioid Use Disorder (MOUD)”, from Food and Drug Administration (FDA),medications approved by the FDA for substance abuse especially opioids include methadone, buprenorphine, and naltrexone.

Misconceptions about MAT include that it replaces one addiction with another, it is only for severe cases, or is not a “real” recovery. The 2020 review “Addressing Misconceptions and Barriers to Medication-Assisted Treatment in Criminal Justice Settings”, from Bureau of Justice Assistance; Comprehensive Opioid, Stimulant, and Substance Abuse Program, indicates that misconceptions  about MAT deter its use, and hinder implementation.

Medication-assisted treatment is significantly effective for addiction treatment including opioid use disorder (OUD), and relapse prevention . The 2018 report “Medications To Treat Opioid Use Disorder Research Report: How Effective Are Medications To Treat Opioid Use Disorder,” from National Institute on Drug Abuse,  demonstrated that patients using methadone were 33% less likely to text positive for opioid use, and 4 times more likely to stay in treatment.

What Is Medication-Assisted Treatment (MAT)?

Medication-assisted treatment (MAT) is a comprehensive approach involving medication and psychotherapy for treating substance use disorders. According to the 2020 study by Deyo-Svendsen, M., “Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice”, published in the Journal of Primary Care & Community Health, MAT combines psychosocial interventions with medications to treat opioid and alcohol addiction.

The approach combines FDA-approved medications, such as methadone and buprenorphine, with counseling and behavioral therapies to address both the physical and psychological aspects of addiction The primary purpose of MAT is to reduce cravings, manage withdrawal symptoms, and support long-term recovery by providing individuals with the tools necessary to achieve a substance-free life. This holistic strategy enhances treatment retention and improves the overall quality of life for those in recovery.

How Does Medication-Assisted Treatment Work in Addiction Treatment?

Medication-assisted treatment works in addiction treatment by easing withdrawal symptoms and cravings, reducing the risk of relapse. According to the review “MAT Works”, from MAT Works Org, medication-assisted treatment assists in reducing cravings, manages withdrawal symptoms, and helps to minimize the risk of overdose during addiction treatment. MAT integrates FDA-approved medications with behavioral therapies to address addiction’s complex neurobiology. 

These medications act on brain receptors, specifically targeting opioid receptors to alleviate withdrawal symptoms and reduce cravings. By restoring neurochemical balance, MAT facilitates craving management, allowing individuals to engage more fully in therapeutic processes. The combination of pharmacological support and counseling enhances motivation and coping skills, addressing both the biological and psychological aspects of addiction, ultimately promoting long-term recovery and stability in patients’ lives.

How Does MAT Integrate into Comprehensive Addiction Treatment Programs?

MAT integrates into comprehensive addiction treatment programs by addressing the physical and psychological aspects of addiction, reducing cravings and withdrawal symptoms while improving treatment retention and outcomes. According to the 2020 review “Medication-Assisted Treatment Models”, from the Rural Health Information Hub, MAT integrates medication with counseling and behavioral therapies for a comprehensive addiction treatment approach. It addresses the physical and psychological aspects of addiction, reducing cravings and withdrawal symptoms while improving treatment retention and outcomes. MAT is not a standalone solution but a crucial component of a holistic recovery plan.

MAT integrates into comprehensive addiction treatment programs as outlined below:

1. Assessment and Planning: Assessment identifies addiction severity and needs. Planning creates a personalized treatment strategy addressing those needs for recovery. Begin with a comprehensive evaluation of the patient’s substance use history and health status. This helps identify appropriate medications and therapies tailored to individual needs.
2. Medication Administration: Medication administration in addiction treatment involves safely dispensing prescribed medications to manage withdrawal, cravings, and co-occurring mental health conditions. Integrate FDA-approved medications to manage withdrawal symptoms, reduce cravings, and stabilize brain chemistry. This pharmacological support is essential for addressing the physical aspects of addiction.
3. Behavioral Therapies: Behavioral therapies in addiction treatment help individuals identify and change harmful thoughts and behaviors associated with substance use. Combine medication with counseling and behavioral therapies to address the psychological and emotional aspects of addiction. This holistic approach enhances coping skills, motivation, and overall recovery.
4. Ongoing Monitoring: In addiction treatment, ongoing monitoring involves continuous assessment and support to track progress, prevent relapse, and adjust treatment as needed. Implement regular assessments to adjust treatment plans based on the patient’s progress, ensuring flexibility in addressing evolving challenges.
5. Support Systems:Support systems in addiction treatment are networks of people and resources that aid recovery by providing encouragement, accountability, and practical help.  Encourage participation in support groups and peer networks to foster community and shared experiences, which are crucial for long-term recovery.

Find renewed hope, purpose, and freedom from addiction

Begin Your Journey to Recovery

Message UsCall Now 732-851-1988

How Does MAT Address Co-occurring Mental Health Conditions?

MAT addresses co-occurring mental health conditions by simultaneously managing substance use disorders and co-occurring mental health conditions such as depression and anxiety. According to the 2015 study by Saunders, E. C., et al “The Impact of Addiction Medications on Treatment Outcomes for Persons With Co-Occurring PTSD and Opioid Use Disorders”, published in the American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, MAT uses medications to stabilize the person affected by addiction to create a stable ground for addressing dual diagnosis including anxiety, and depression. 

Additionally, specific medications, like buprenorphine and methadone, not only alleviate withdrawal symptoms but also stabilize mood and reduce anxiety, enhancing overall recovery outcomes. This integrated treatment approach combines medication with counseling and behavioral therapies, allowing individuals to develop coping skills while addressing both their addiction and mental health issues concurrently, ultimately improving treatment success and quality of life.

How Does MAT Combine with Behavioral Therapies?

Medication-assisted treatment (MAT) combines medications with behavioral therapies, such as CBT and group therapy, to enhance recovery from substance use disorders. According to the review “Medication-Assisted Treatment FAQ”, from the Illinois Department of Public Health, MAT combines medication and psychotherapy to address both the physical symptoms of withdrawal and the psychological aspects of addiction, improving treatment retention and success rates. 

CBT helps individuals identify and modify negative thought patterns, while group therapy provides social support and accountability. Together, these therapies foster healthier coping mechanisms and reduce the risk of relapse, leading to more sustainable recovery outcomes.

Is MAT Effective When Used Alone or Must It Be Combined?

MAT is most effective when combined with behavioral therapies, as it addresses both the neurobiological and psychological aspects of substance use disorders. According to the review “Understanding the Components of Medication-Assisted Treatment”, from the Agency for Healthcare Research and Quality, MAT is effective in treating substance abuse disorders when combined with psychotherapy because it addresses the needs of the whole person. 

While MAT alone reduces cravings and improves retention rates, its standalone effectiveness varies significantly among individuals. The review “ The Truth About MAT”, from Oklahoma Mental Health&Substance Abuse lowers opioid overdose mortality by up to 75% compared to non-treatment groups. However, integrating MAT with cognitive-behavioral therapy enhances overall treatment outcomes, making a combined approach essential for sustained recovery.

Which Medications Are Used in MAT?

The medications used in MAT include buprenorphine, methadone, and naltrexone. According to the 2020 review “Drugs, Brains, and Behavior: The Science of Addiction Treatment and Recovery”, from the National Institute on Drug Abuse, MAT uses medications such as methadone, buprenorphine, naltrexone, and disulfiram to treat substance use disorders.

The medications used in MAT include:

1. Methadone 

Methadone is a synthetic opioid, classified as a full opioid agonist, primarily used to treat opioid use disorder (oud) and manage chronic pain. According to the review “ What Is Methadone”,  from UAMS Psychiatric Research Institute, methadone alleviates withdrawal symptoms and cravings, allowing individuals to stabilize their lives. Dosages are tailored to individual needs, typically administered once daily, with effects lasting 24 to 36 hours. Potential methadone risks include respiratory depression, overdose, and potential for abuse, particularly at higher doses. This treatment is most effective when combined with counseling and behavioral therapies.

2. Buprenorphine (Suboxone)

Buprenorphine is a synthetic opioid used in MAT for opioid addiction. According to the 2024 study by Kumar R., et al, “Buprenorphine”, from StatPearls, buprenorphine, a partial agonist, is mainly used to treat opioid use disorder, as a milder substitute for a potent full agonist opioid such as heroin. As a partial agonist at the mu-opioid receptor, it activates these receptors but with less intensity than full agonists like heroin or methadone, which helps to alleviate withdrawal symptoms and cravings without producing significant euphoria.

This unique profile results in a ceiling effect, reducing the risk of overdose and dependency compared to traditional opioids. Buprenorphine’s safety profile makes it a preferred choice for withdrawal management in individuals recovering from opioid addiction.

3. Naltrexone (Vivitrol)

Naltrexone, marketed as Vivitrol, is an opioid antagonist used primarily to treat alcohol and opioid dependence. According to the 2024 review “Naltrexone”, from Substance Abuse and Mental Health Services Administration, is used to treat alcohol use disorder (AUD), and opioid use disorder (OUD). It works by blocking the euphoric effects of these substances, thus aiding in relapse prevention.

As a non-addictive medication, it does not produce “high” or withdrawal symptoms, making it safe for long-term use. Vivitrol is administered via intramuscular injection once a month, providing a steady release of naltrexone that helps reduce cravings and prevents relapse in individuals recovering from substance use disorders.

Are There Any Emerging Medications or Alternatives for MAT?

Yes, there are emerging medications and alternatives for MAT such as nalmefene, and kratom. According to the 2020 study by Leyrer-Jackson, J. M., et al, “Current And Emerging Pharmacotherapies For Opioid Dependence Treatments In Adults: A Comprehensive Update”, published in Expert Opinion on Pharmacotherapy Journal, emerging and alternative medication for MAT include kratom and tramadol.

Nalmefene is gaining attention as a potential treatment for opioid use disorder (OUD). According to the 2014 study by Paille F, et al, “Nalmefene: a new approach to the treatment of alcohol dependence”, published in Substance Abuse and Rehabilitation Journal, nalmefene helps to reduce alcohol consumption.

The drug acts as a potent opioid receptor antagonist, showing promise in maintaining treatment for substance use disorders. However, further research is needed due it has the potential to cause side effects leading to discontinuation of therapy. Apart from nalmefene, GLP-1 agonists, used for diabetes and obesity, are being considered for their ability to reduce cravings associated with substance use disorders.

Kratom, a herbal extract, is under investigation as a potential alternative medication for opioid withdrawal and chronic pain management as demonstrated in the 2020 study by Leyrer. While it has been used traditionally for treating various ailments including managing anxiety, research is ongoing to evaluate its safety and efficacy as a therapeutic option.

What Are the Common Misconceptions About MAT?

Common misconceptions about MAT are that MAT substitutes one addiction for another, MAT is not real recovery, and MAT is only for opioid addiction. According to the 2018 review “Medications to Treat Opioid Use Disorder Research Report: What Are Misconceptions About Maintenance Treatment”, from the National Institute on Drug Abuse, maintenance medications such as buprenorphine, and methadone are opioids, as a result, people assume that people who use them to treat addiction are just substituting one substance use disorder with another.

The common misconceptions are:

• MAT Substitutes One Addiction For Another: This misconception suggests that Medication-Assisted Treatment (MAT) merely replaces one substance dependency with another. In reality, MAT uses FDA-approved medications like methadone and buprenorphine to help stabilize individuals with opioid use disorder (OUD) by alleviating withdrawal symptoms and cravings, not creating a new addiction. To help debunk this misconception further, it is important to understand dependency vs. addiction. Dependency refers to the body’s adaptation to a substance, leading to withdrawal symptoms without it, while addiction involves compulsive behavior despite negative consequences. MAT aims to manage dependency through regulated medication use, allowing individuals to function without the compulsive behaviors associated with addiction.
• MAT Is Not Real Recovery: This myth claims that MAT does not contribute to genuine recovery. However, MAT is designed to support recovery by managing withdrawal symptoms, which often lead to relapse if left unaddressed. It integrates behavioral therapies alongside medication, helping individuals regain control over their lives and facilitating a sustainable recovery journey.
• MAT Is Only For Opioid Addiction. While MAT is widely known for its role in opioid addiction treatment, it is also highly effective in treating alcohol dependence.
• Dependency vs. Addiction: Dependency refers to the body’s adaptation to a substance, leading to withdrawal symptoms without it, while addiction involves compulsive behavior despite negative consequences. MAT aims to manage dependency through regulated medication use, allowing individuals to function without the compulsive behaviors associated with addiction.
• Is MAT A Form Of Harm Reduction: Yes, MAT is a significant harm reduction strategy. Harm reduction focuses on minimizing the negative consequences of substance use rather than solely aiming for abstinence. According to the 2023 report “Embracing Recovery-Oriented Harm Reduction in Medication Assisted Treatment”,  from the Association for Addiction Professionals, MAT reduces overdose deaths and improves recovery rates by providing a safer alternative that stabilizes individuals and decreases illicit drug use.

Are There Potential Risks Of Medication Diversion Or Misuse In MAT?

Yes, there are potential risks of medication diversion or misuse in MAT. The 2018 report “Medications to Treat Opioid Use Disorder Research Report: What Are Misconceptions About Maintenance Treatment”, from the National Institute on Drug Abuse, indicates that drugs used in MAT including methadone and buprenorphine are misused and diverted in some instances, just like other opioids or prescription medication.

The risk of misuse and diversion arises from the nature of the medications used, such as buprenorphine and methadone, which produce euphoric effects when misused. In correctional settings, individuals divert their prescribed medications through methods like “cheeking,” where they conceal the drugs in their mouths to later sell or share them with others. According to the review “Medication-assisted Treatment Inside Correctional Facilities”, by the Substance Abuse and Mental Health Services Administration, the diversion leads to serious consequences, including increased substance use disorders, overdose risks, and legal repercussions for both the individuals involved and healthcare providers.

To mitigate these risks, dedicated staff trained in MAT protocols must monitor medication administration closely. This includes conducting dual mouth checks and using observation tables during medication distribution to ensure compliance. In addition, patient-centered treatment planning that involves collaboration between medical staff, correctional personnel, and patients fosters a supportive environment that encourages adherence to treatment plans.

What Are the Benefits of Using MAT in Addiction Recovery?

The benefits of using MAT in addiction recovery are reducing cravings, decreasing the risk of overdose, alleviating withdrawal symptoms, preventing relapses, enhancing treatment retention, and improving overall well-being. According to the review “Medication for Addiction Treatment”, from the Office of Addiction Services and Supports, MAT reduces the risk of overdose and decreases the risk of overdose deaths. 

The benefits of using MAT in addiction recovery are given below:

• Reducing Cravings: MAT effectively curbs or eliminates intense cravings for drugs or alcohol, making it easier for individuals to focus on recovery.
• Decreasing The Risk Of Overdose: MAT reduces overdose risk by curbing cravings and withdrawal, decreasing the likelihood of relapse and subsequent overdose, and overdose deaths.
• Alleviating Withdrawal Symptoms: The medications used in MAT help lessen the pain and discomfort associated with withdrawal, facilitating a smoother detox process.
• Preventing Relapses: By stabilizing brain function and normalizing body chemistry, MAT significantly decreases the likelihood of relapse, allowing individuals to navigate triggers more effectively.
• Enhancing Treatment Retention: Patients undergoing MAT are more likely to stay engaged in their treatment programs, which contributes to better recovery outcomes.
• Improving Overall Well-being: MAT not only aids in managing addiction symptoms but also enhances mental health, relationships, and overall quality of life, leading to a more fulfilling life post-recovery.

How Effective Is MAT Compared to Other Approaches in Addiction Treatment?

MAT is significantly effective compared to other approaches in addiction treatment. According to the 2023 study by Mallory L., “Treating Opioid Disorder Without Meds More Harmful Than No Treatment At All”, published in Yale News, using MAT such as buprenorphine, and methadone decreased the risk of death due to opioid overdose by 34% and 38%, respectively, compared to abstinence-only.

Additionally, other studies reveal significantly higher success rates for MAT in reducing relapse and promoting long-term recovery, particularly for opioid use disorder. A 2016 study “Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health “, published by the Substance Abuse and Mental Health Services Administration indicates that nearly half of the individuals using MAT successfully managed their opioid dependence, compared to 7% in abstinence-based programs.   

While abstinence-only programs are beneficial for some people, they lack the necessary support to manage intense cravings and withdrawal symptoms, leading to higher relapse rates. Other approaches like counseling and therapy are crucial components of addiction treatment but are not sufficient on their own for individuals with severe addictions. MAT addresses the physical and psychological aspects of addiction, providing a more comprehensive and effective approach to recovery.

Why Is MAT More Effective Than Abstinence-Only Approaches for Opioid Use Disorder?

MAT is more effective than abstinence-only approaches for opioid use disorder due to its comprehensive approach. According to the 20202 review “Drugs, Brains, and Behavior: The Science of Addiction Treatment and Recovery”, from the National Institute on Drug Abuse, MAT is more effective than abstinence-only approaches for opioid use disorder because medications manage, and reduce withdrawal symptoms, prevent cravings, and relapse.

MAT’s combination of medication with psychotherapy addresses both the physical and psychological aspects of addiction. The combination helps to reduce cravings and withdrawal symptoms, assisting individuals to manage their addiction and reducing the risk of relapse. 

MAT leads to better long-term outcomes than abstinence-only approaches. A 2018 study by Margaret A. M ., “Effects Of Medication Assisted Treatment (Mat) For Opioid Use Disorder On Functional Outcomes: A Systematic Review”,  published in the Journal of Substance Abuse Treatment found that patients receiving MAT had a 50% lower risk of relapse compared to those receiving psychosocial treatment alone.

How Long Does It Take for MAT to Show Results?

It takes about 3-6 months for MAT to show results (MAT), however, addiction treatment and response is highly individualized, and the length of time it takes to show results usually varies. According to the 1999 review “Principles Of Drug Addiction Treatment”, by National Institute on Drug Abuse (NIDA), it takes approximately three months for MAT to show results. Factors influencing the duration MAT takes to show results include the substance used, the severity of the addiction, and the presence of co-occurring disorders.

While longer programs generally lead to better outcomes, even short courses of MAT significantly reduce the risk of overdose. For methadone, a 12-month program is recommended, while buprenorphine needs to be taken for at least six months to prevent relapse. The 1999 review by NIDA indicates that remaining in MAT programs longer results in better outcomes regarding sobriety and avoiding relapse.

Who Should Consider Medication-Assisted Treatment?

People who should consider medication-assisted treatment include people with substance dependence, individuals with severe addiction, and those with a relapse history. According to the 2022 report “DEA’s Commitment to Expanding Access to Medication-Assisted Treatment”, from the United States Drug Enforcement Administration, MAT is ideal for people diagnosed with substance abuse disorder who are interested in treatment. 

Eligibility criteria for MAT include:

• People with Substance Dependence A diagnosis of substance dependence is a primary criterion for participation in MAT programs.
• Interest In Addiction Treatment: Patients who are willing to participate in addiction treatment.
• Withdrawal State: Patients in a state of withdrawal are candidates for admission.
• Relapse History: Individuals with multiple unsuccessful detoxification attempts within a year should be assessed for MAT. Those who relapse once or multiple times should receive a higher level of care.
• Severe Addiction: Patients with chronic, compulsive drug-seeking behavior meet the MAT eligibility criteria.

How Can You Access Medication-Assistent Treatment for Addiction?

You can access medication-assisted treatment for addiction by finding a provider, undergoing assessment, medical detox, rehabilitation, and medical maintenance. According to the 1997 review “A Guide to Substance Abuse Services for Primary Care Clinicians” by the Substance Abuse and Mental Health Services Administration, there are community, and state-level resources, including directories that provide information on addiction treatment, and authorities that run drug and alcohol treatment programs. MAT is an extremely important part of addiction treatment. 

To access medication-assisted treatment for addiction, below is a step-by-step guide:

1. Find a Provider: Look for licensed treatment centers, psychiatrists, psychologists, or licensed alcohol and drug counselors. Directories from local health departments, social services organizations, or the National Council on Alcohol and Drug Dependence will help.
2. Assessment: A physician assesses your needs to determine the appropriate MAT course and medications.
3. Medical Detox: Begin with medical detox to stabilize during substance withdrawal.
4. Rehabilitation: Participate in a treatment program that combines medication and therapy to address life issues and prevent relapse.
5. Medical Maintenance: Transition to long-term medication to manage substance use disorder.

What Should You Expect in a MAT Program?

You should expect an MAT program to include intake and assessment, treatment planning,  pharmacological therapy, psychosocial services, monitoring, care coordination, education, and outreach. According to a 2019 review “Medication Assisted Treatment Program”, from the American Society of Addiction Medicine, when you join an addiction treatment program, expect to discuss treatment options with your provider, take physical and lab tests, and make an induction appointment to start on MAT.

Below are the components to expect in a MAT program that contribute to the overall program structure:

1. Intake and Assessment: The MAT program typically starts with a comprehensive assessment to gather historical information, including substance use, psychiatric, medical, and social history. This involves interviews, mental status examinations, and screening tools. A focused physical assessment and review of systems may also be conducted.
2. Treatment Planning: Based on the assessment, a treatment plan is developed, which includes MAT treatment planning activities.
3. Pharmacological Therapy: MAT utilizes prescribed medications to aid in the treatment of substance use disorders. This component involves ordering, prescribing, and administering medications.
4. Psychosocial Services: Apart from medication, MAT programs offer psychosocial support, which includes counseling, peer support, and family involvement. MAT groups meet regularly, especially in the early weeks of treatment, to provide support, address side effects, and ensure proper dosage.
5. Monitoring: Regular monitoring is conducted to observe for signs of substance use or withdrawal and to track progress.
6. Care Coordination: MAT programs often include care coordination activities to ensure integrated care.
7. Education and Outreach: MAT programs provide education about medication, and living without using substances.

How Are MAT Services Administered?

MAT services are administered through daily clinic visits, prescriptions for take-home doses, and injections. According to the 2022 review “Drug Addiction (Substance Use Disorder)”, from Mayo Clinic, substance use disorder medications are administered nasally as a spray, orally, or as injections. These programs usually follow a harm-reduction model, providing compassionate support without judgment.

MAT services are administered through various methods tailored to the patient’s needs, including daily clinic visits for direct medication administration, prescriptions for take-home doses, and injections. For instance, a patient visits a clinic daily to receive a dose of methadone, or a doctor prescribes buprenorphine for the patient to take at home. Additionally, injectable medications like Vivitrol are available.

What Are the Typical Costs and Insurance Coverage for MAT?

Typical costs and insurance coverage for MAT are estimated at $400 monthly for buprenorphine treatment, and $350 to $550 per month for methadone treatment. However, the costs and insurance coverage for MAT varies based on medication type, insurance plan,dosage, and frequency of visits, as well as doctor’s fees, counseling, and lab tests. The 2018 report “Medications to Treat Opioid Use Disorder Research Report: How Much Does Opioid Treatment Cost”, from National Institute on Drug Abuse, indicates that weekly methadone treatment including psychosocial and medical interventions costs about $126.00, while buprenorphine treatment including bi-weekly visits and other interventions for the average patient costs $115.00 per week.

Insurance coverage, including private, Medicaid, and Medicare plans, often covers MAT, but coverage does not always mean it is free. Normally, out-of-pocket expenses are significant without insurance. The Affordable Care Act requires most insurance policies to cover medically necessary substance use disorder treatment. While some plans cover MAT fully, others only offer partial coverage.

Where Can You Find Reliable MAT Providers?

You can find reliable MAT providers through the Substance Abuse and Mental Health Services Administration ( SAMHSA) National Helpline 1-800-662-HELP (4357).  SAMHSA offers a provider directory, which is a valuable resource. Additionally, when you consult your health insurance provider, they will provide you with a list of MAT doctors covered by your plan. Finally, the National Association of Addiction Treatment Providers Addiction Industry Directory also serves as a comprehensive source of addiction service providers.

When evaluating providers, look for certified providers with the appropriate credentials to administer MAT. Seek out reviews and testimonials from previous patients to gauge the quality of care and effectiveness of the treatment. In addition, ensure the provider offers a comprehensive approach, including medication management, therapy, and support services.

What Are the Key Regulations Governing MAT?

Key regulations governing MAT the MAT Act, MATE Act, and SUPPORT Act. According to the 2024 review “Statutes, Regulations, and Guidelines”, from SAMHSA, regulations governing MAT include Controlled Substances Act (CSA), Waiver Elimination (MAT Act), and Training Requirements (MATE Act) Resources. The MAT Act eliminated the DATA Waiver (or X waiver) requirement, allowing authorized providers to prescribe buprenorphine for OUD without needing to register with the DEA. 

The MATE Act requires healthcare providers, with the exception of veterinarians, to complete a one-time, eight-hour training on managing patients with substance use disorders when obtaining or renewing their registration to prescribe potentially addictive drugs. The SUPPORT Act mandates that state Medicaid plans cover MAT drugs, biological products, counseling services, and behavioral therapy. For methadone, federal law dictates it is only dispensed through certified Opioid Treatment Programs (OTPs).

How Does MAT Compare to Opioid Treatment Programs (OTP)?

MAT uses medications like methadone or buprenorphine to manage opioid cravings and withdrawal, while OTPs are structured programs that combine MAT with counseling and support services. According to the review “Medication-Assisted Treatment (MAT) in Virginia”, from the Department of Behavioral Health and Developmental Services, OTP is a more comprehensive and customized treatment compared to MAT. 

An Opioid Treatment Program (OTP) is a program that provides opioid treatment with an opioid agonist medication. Federal regulations mandate a range of medical and rehabilitative services, when clinically necessary, for individuals to alleviate the adverse effects of opiate addiction.

MAT vs. OTP Comparison Table

Aspect	Medication-Assisted Treatment (MAT)	Opioid Treatment Program (OTP)
Scope of Treatment	Combines FDA-approved medications with counseling and behavioral therapies, offering a “whole-patient” approach by addressing the physical, psychological, and social aspects of addiction.	Combines medication-assisted treatment (MAT) with counseling and support services, ensuring holistic care that addresses the physical, psychological, and social aspects of addiction.
Medication Options	Medications that address the physiological aspects of addiction. Includes buprenorphine and naltrexone.	FDA-approved medication-assisted treatment drugs like methadone, buprenorphine, and naltrexone2. OTPs are the only setting in which methadone can be legally prescribed.
Regulation	Treatment can be integrated into general medical practices.	Highly controlled recovery environment based on state and federal laws. The Substance Abuse and Mental Health Services Administration (SAMHSA) regulates OTPs at the federal level and outlines certification requirements and standards for the accreditation process.
Delivery Model	Office-Based Opioid Treatment (OBOT) programs allow practitioners to prescribe medications for opioid use disorder, enabling patients to self-dispense medication at home with periodic check-ins.	Structured treatment programs involving accredited clinicians. Patients typically visit an OTP daily to take medication under staff supervision onsite.
Accessibility	More flexible and accessible; treatment for OUD can occur outside a controlled OTP, including in the same setting where patients receive other medical care, which can reduce stigma and make treatment more accessible, especially in rural areas.	Shortage of OTPs across the United States, especially in rural areas, which is a major barrier to MOUD access in rural communities.
Suitability	Consider individual needs, preferences, and the severity of the condition.	Impact the lives of those struggling with opioid dependency, offering a path to a healthier future.

MAT primarily focuses on medications to address the physiological aspects of addiction, while OTPs emphasize a more comprehensive, therapy-based approach. Understanding the differences between MAT and OTP programs is crucial for individuals seeking treatment for opioid addiction to make informed decisions about their recovery pathway.